Home / Inspections / 1261727

FDA Inspection 1261727 — Somerset Therapeutics Private Limited

Somerset Therapeutics Private Limited — FEI 3003821988

The FDA completed an inspection of Somerset Therapeutics Private Limited on February 21, 2025 in Bengaluru. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Facility

Other inspections at this facility

  • 1226714 (VAI Fri Oct 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1166834 (OAI Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118121 (OAI Wed Feb 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097269 (VAI Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1038093 (VAI Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources